Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 4
2010 5
2011 9
2012 6
2013 7
2014 5
2015 6
2016 11
2017 11
2018 14
2019 10
2020 22
2021 25
2022 32
2023 38
2024 21

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Results by year

Filters applied: . Clear all
Page 1
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850).
Fagotti A, Ferrandina MG, Vizzielli G, Pasciuto T, Fanfani F, Gallotta V, Margariti PA, Chiantera V, Costantini B, Gueli Alletti S, Cosentino F, Scambia G. Fagotti A, et al. Among authors: vizzielli g. Int J Gynecol Cancer. 2020 Nov;30(11):1657-1664. doi: 10.1136/ijgc-2020-001640. Epub 2020 Oct 7. Int J Gynecol Cancer. 2020. PMID: 33028623 Clinical Trial.
Management of Patients Diagnosed with Endometrial Cancer: Comparison of Guidelines.
Restaino S, Paglietti C, Arcieri M, Biasioli A, Della Martina M, Mariuzzi L, Andreetta C, Titone F, Bogani G, Raimondo D, Perelli F, Buda A, Petrillo M, Greco P, Ercoli A, Fanfani F, Scambia G, Driul L, Vizzielli G; The Udine Hospital Gynecological-Oncological Tumor Board Group. Restaino S, et al. Among authors: vizzielli g. Cancers (Basel). 2023 Feb 8;15(4):1091. doi: 10.3390/cancers15041091. Cancers (Basel). 2023. PMID: 36831434 Free PMC article. Review.
Dual inhibition of CDK12 and CDK13 uncovers actionable vulnerabilities in patient-derived ovarian cancer organoids.
Cesari E, Ciucci A, Pieraccioli M, Caggiano C, Nero C, Bonvissuto D, Sillano F, Buttarelli M, Piermattei A, Loverro M, Camarda F, Greco V, De Bonis M, Minucci A, Gallo D, Urbani A, Vizzielli G, Scambia G, Sette C. Cesari E, et al. Among authors: vizzielli g. J Exp Clin Cancer Res. 2023 May 18;42(1):126. doi: 10.1186/s13046-023-02682-5. J Exp Clin Cancer Res. 2023. PMID: 37202753 Free PMC article.
Editorial: Molecular influences in therapies in ovarian cancer.
Restaino S, Wei JJ, Vizzielli G, Martinelli F. Restaino S, et al. Among authors: vizzielli g. Front Oncol. 2022 Aug 8;12:991769. doi: 10.3389/fonc.2022.991769. eCollection 2022. Front Oncol. 2022. PMID: 36003794 Free PMC article. No abstract available.
Predicting Response to Anthracyclines in Ovarian Cancer.
Ferrero A, Borghese M, Restaino S, Puppo A, Vizzielli G, Biglia N. Ferrero A, et al. Among authors: vizzielli g. Int J Environ Res Public Health. 2022 Apr 2;19(7):4260. doi: 10.3390/ijerph19074260. Int J Environ Res Public Health. 2022. PMID: 35409939 Free PMC article. Review.
195 results